Skip to content
Home » Insights » Trust in Science Is No Longer Guaranteed — Here’s What HCPs Really Believe

Trust in Science Is No Longer Guaranteed — Here’s What HCPs Really Believe

Advocacy As A Bridge

For decades, science spoke for itself. Strong evidence was enough to earn belief and adoption. That is no longer the case.

Surveys consistently show a decline in trust among healthcare professionals (HCPs) and the wider public. Factors such as misinformation, digital noise, and scepticism towards industry have created a credibility gap that even the best data cannot close on its own.

  • A Wellcome Global Monitor survey found that almost half of adults worldwide are unsure whether they can trust science.
  • Studies in medical affairs show that HCPs increasingly filter information through peer influence and digital channels rather than published evidence alone.
  • In ophthalmology and medtech, where innovation moves fast, new products can be met with hesitation if the right experts are not shaping the narrative.

The Cost of the Credibility Gap

When evidence is seen but not believed, launches stall. Activity increases but influence declines. Programmes that fail to address credibility risk disengaged experts, wasted investment, and slower adoption.

Advocacy as the Bridge

This is where advocacy must adapt.

  • The right voices: engaging experts who are trusted, not just visible.
  • The right narrative: shaping stories that create confidence, not just awareness.
  • The right continuity: building long-term belief, not stop–start engagement.

Advocacy, designed well, does more than communicate data. It makes evidence trusted, actionable, and influential.

How ArtiaCo. Helps

At ArtiaCo., we partner with companies to close the credibility gap. Our framework identifies the experts who matter, build narratives that resonate, and sustain engagement that proves value.

Because when science is trusted, innovation succeeds.

Bernie Ursell - With 25+ years in medical communications — including senior roles at ZEISS, AbbVie and Allergan — Bernie offers deep experience in messaging, compliance and international healthcare strategy. She’s helped shape the narratives behind some of the biggest names in eye care and knows how to elevate expert voices with clarity and credibility.